Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 2
1993 7
1994 5
1995 2
1999 2
2000 1
2002 2
2003 1
2006 2
2009 7
2010 7
2011 3
2012 2
2013 3
2014 3
2015 7
2016 6
2017 2
2019 3
2020 2
2021 2
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Genetic screening: birthright or earned with age?
Mollison L, Berg JS. Mollison L, et al. Expert Rev Mol Diagn. 2017 Aug;17(8):735-738. doi: 10.1080/14737159.2017.1346473. Epub 2017 Jun 29. Expert Rev Mol Diagn. 2017. PMID: 28641021 Free PMC article. No abstract available.
Antibiotic resistance in Helicobacter pylori.
Mollison LC, Stingemore N, Wake RA, Cullen DJ, McGechie DB. Mollison LC, et al. Med J Aust. 2000 Nov 20;173(10):521-3. doi: 10.5694/j.1326-5377.2000.tb139319.x. Med J Aust. 2000. PMID: 11194734
Hepatitis due to nitrofurantoin.
Mollison LC, Angus P, Richards M, Jones RM, Ireton J. Mollison LC, et al. Med J Aust. 1992 Mar 2;156(5):347-9. doi: 10.5694/j.1326-5377.1992.tb139795.x. Med J Aust. 1992. PMID: 1588868
FibroGENE: A gene-based model for staging liver fibrosis.
Eslam M, Hashem AM, Romero-Gomez M, Berg T, Dore GJ, Mangia A, Chan HLY, Irving WL, Sheridan D, Abate ML, Adams LA, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Nattermann J, Riordan S, Miele L, Kelaeng KS, Ampuero J, Ahlenstiel G, McLeod D, Powell E, Liddle C, Douglas MW, Booth DR, George J; International Liver Disease Genetics Consortium (ILDGC). Eslam M, et al. Among authors: mollison l. J Hepatol. 2016 Feb;64(2):390-398. doi: 10.1016/j.jhep.2015.11.008. Epub 2015 Dec 1. J Hepatol. 2016. PMID: 26592354 Free article.
Engaging community stakeholders in research on best practices for clinical genomic sequencing.
Griesemer I, Staley BS, Lightfoot AF, Bain L, Byrd D, Conway C, Grant TL, Leach B, Milko L, Mollison L, Porter N, Reid S, Smith G, Waltz M, Berg JS, Rini C, O'Daniel JM. Griesemer I, et al. Among authors: mollison l. Per Med. 2020 Nov;17(6):435-444. doi: 10.2217/pme-2020-0074. Epub 2020 Oct 7. Per Med. 2020. PMID: 33026293 Free PMC article.
Evaluation of a new formulation CLOtest.
Viiala CH, Windsor HM, Forbes GM, Chairman SO, Marshall BJ, Mollison LC. Viiala CH, et al. Among authors: mollison lc. J Gastroenterol Hepatol. 2002 Feb;17(2):127-30. doi: 10.1046/j.1440-1746.2002.02563.x. J Gastroenterol Hepatol. 2002. PMID: 11966940 Clinical Trial.
Integration of stakeholder engagement from development to dissemination in genomic medicine research: Approaches and outcomes from the CSER Consortium.
O'Daniel JM, Ackerman S, Desrosiers LR, Rego S, Knight SJ, Mollison L, Byfield G, Anderson KP, Danila MI, Horowitz CR, Joseph G, Lamoure G, Lindberg NM, McMullen CK, Mittendorf KF, Ramos MA, Robinson M, Sillari C, Madden EB; CSER Stakeholder and Engagement Work Group. O'Daniel JM, et al. Among authors: mollison l. Genet Med. 2022 May;24(5):1108-1119. doi: 10.1016/j.gim.2022.01.008. Epub 2022 Feb 25. Genet Med. 2022. PMID: 35227608 Free PMC article.
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M; ASTRAL-2 Investigators; ASTRAL-3 Investigators. Foster GR, et al. N Engl J Med. 2015 Dec 31;373(27):2608-17. doi: 10.1056/NEJMoa1512612. Epub 2015 Nov 17. N Engl J Med. 2015. PMID: 26575258 Free article. Clinical Trial.
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
Eslam M, McLeod D, Kelaeng KS, Mangia A, Berg T, Thabet K, Irving WL, Dore GJ, Sheridan D, Grønbæk H, Abate ML, Hartmann R, Bugianesi E, Spengler U, Rojas A, Booth DR, Weltman M, Mollison L, Cheng W, Riordan S, Mahajan H, Fischer J, Nattermann J, Douglas MW, Liddle C, Powell E, Romero-Gomez M, George J; International Liver Disease Genetics Consortium (ILDGC). Eslam M, et al. Among authors: mollison l. Nat Genet. 2017 May;49(5):795-800. doi: 10.1038/ng.3836. Epub 2017 Apr 10. Nat Genet. 2017. PMID: 28394349 Free article.
70 results